Clinical trial
Intravenous Oxytocin for Post Operative Pain After Minimally Invasive Hysterectomy
NCT06483659 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intravenous Oxytocin for Post Operative Pain After Minimally Invasive Hysterectomy
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- June 1, 2025
- Completion date
- June 30, 2028
- Enrollment
- 152 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.